Europe and MENA Wound Care Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 – 2032
Europe And MENA Wound Care Market, valued at around USD 7.5 billion in 2023, is anticipated to grow at a 6% CAGR from 2024 to 2032. Wound care involves the medical treatment of injuries to the skin or underlying tissues, which can be caused by trauma, surgery, or chronic conditions. Key goals in wound care include promoting healing, preventing infections, and minimizing scarring. Rising cases of chronic wounds, such as diabetic foot and pressure ulcers, are driving demand for advanced wound care solutions across Europe and the Middle East. In Europe, an estimated four million individuals suffer from chronic wounds annually, underscoring the urgent need for effective wound care products.
Technological advancements like bioactive dressings and negative pressure wound therapy are enhancing treatment outcomes, while the Middle East’s growing healthcare infrastructure is supporting greater access to advanced wound care solutions. By product, the market is divided into advanced wound dressings, surgical wound care, traditional wound care, wound therapy devices, and wound care biologics. Advanced wound dressings, valued at USD 2.4 billion in 2023, lead the market due to their effectiveness in accelerating the healing process. These dressings create optimal healing environments, reduce infection risk, and are especially valuable for managing chronic wounds.
The market is also segmented by application, into chronic and acute wounds. Chronic wounds include diabetic foot ulcers, pressure ulcers, and venous leg ulcers, while acute wounds cover injuries such as surgical incisions and traumatic wounds. The acute wounds segment, valued at USD 4.2 billion in 2023, currently dominates due to the high volume of trauma and surgical injuries requiring immediate care. Further segmentation by purchase mode shows a strong preference for prescribed products, which held a revenue share of USD 5.4 billion in 2023. The increasing prevalence of chronic conditions, alongside an aging population, is bolstering demand for physician-recommended solutions.
Prescribed treatments often involve advanced dressings and antimicrobial agents that help promote faster recovery while preventing complications. In terms of end-use, hospitals held the largest market share, with revenue at USD 3 billion in 2023. Hospitals are adopting innovative wound care technologies and expanding their wound management services to address the rising incidence of chronic wounds in older populations. Projected to reach USD 12.7 billion by 2032, the Europe and MENA wound care market is seeing strong demand in Europe, particularly due to high rates of chronic diseases. In the UK, an aging population and a shift toward outpatient wound care are likely to drive further market growth.
- Chapter 1 Methodology & Scope
- 1.1 Market scope & definitions
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
- 1.4 Forecast model
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources
- Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis
- Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Increasing number of surgical procedures
- 3.2.1.2 Rising demand for wound care products owing to the ongoing war in Gaza
- 3.2.1.3 Rising prevalence of diabetes
- 3.2.1.4 Growing technological advancements in wound care products
- 3.2.1.5 Rise in number of trauma cases
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 Improper wound management due to lack of awareness of advanced wound care products in emerging economies
- 3.2.2.2 High cost associated with advance wound care products
- 3.3 Growth potential analysis
- 3.4 Future market trends
- 3.5 Regulatory landscape
- 3.6 Technological landscape
- 3.7 Gap analysis
- 3.8 Porter’s analysis
- 3.9 PESTEL analysis
- Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company market share analysis
- 4.3 Competitive analysis of major market players
- 4.4 Competitive positioning matrix
- 4.5 Strategy outlook matrix
- Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
- 5.1 Key trends
- 5.2 Advanced wound dressings
- 5.2.1 Foam dressings
- 5.2.2 Hydrocolloid dressings
- 5.2.3 Film dressings
- 5.2.4 Alginate dressings
- 5.2.5 Hydrogel dressings
- 5.2.6 Collagen dressings
- 5.2.7 Other advanced dressings
- 5.3 Surgical wound care
- 5.3.1 Sutures & staplers
- 5.3.2 Tissue adhesives and sealants
- 5.3.3 Anti-infective dressings
- 5.4 Traditional wound care
- 5.4.1 Medical tapes
- 5.4.2 Cotton
- 5.4.3 Bandages
- 5.4.4 Gauzes
- 5.4.5 Sponges
- 5.4.6 Cleansing agents
- 5.5 Wound therapy devices
- 5.5.1 Negative pressure wound therapy
- 5.5.2 Oxygen and hyperbaric oxygen equipment
- 5.5.3 Electric stimulation devices
- 5.5.4 Pressure relief devices
- 5.5.5 Other wound therapy devices
- 5.6 Wound care biologics
- 5.6.1 Skin substitutes
- 5.6.1.1 Biological
- 5.6.1.2 Allograft
- 5.6.1.3 Xenograft
- 5.6.1.4 Other biologicals
- 5.6.1.5 Synthetic
- 5.6.2 Topical agents
- Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
- 6.1 Key trends
- 6.2 Chronic wounds
- 6.2.1 Diabetic foot ulcers
- 6.2.2 Pressure ulcers
- 6.2.3 Venous leg ulcers
- 6.2.4 Other chronic wounds
- 6.3 Acute wounds
- 6.3.1 Surgical wounds
- 6.3.2 Traumatic wounds
- 6.3.3 Burns
- Chapter 7 Market Estimates and Forecast, By Mode of Purchase, 2021 – 2032 ($ Mn)
- 7.1 Key trends
- 7.2 Prescribed
- 7.3 Non-prescribed
- Chapter 8 Market Estimates and Forecast, By End Use, 2021 – 2032 ($ Mn)
- 8.1 Key trends
- 8.2 Hospitals
- 8.3 Specialty clinics
- 8.4 Home care settings
- 8.5 Other end users
- Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
- 9.1 Key trends
- 9.2 Europe
- 9.2.1 Germany
- 9.2.2 UK
- 9.2.3 France
- 9.2.4 Italy
- 9.2.5 Spain
- 9.2.6 Russia
- 9.2.7 Poland
- 9.2.8 Ukraine
- 9.2.9 Romania
- 9.2.10 Netherlands
- 9.2.11 Belgium
- 9.2.12 Sweden
- 9.2.13 Czech Republic
- 9.2.14 Greece
- 9.2.15 Portugal
- 9.2.16 Hungary
- 9.2.17 Austria
- 9.2.18 Switzerland
- 9.2.19 Serbia
- 9.2.20 Bulgaria
- 9.2.21 Denmark
- 9.2.22 Slovakia
- 9.2.23 Finland
- 9.2.24 Norway
- 9.2.25 Ireland
- 9.2.26 Croatia
- 9.2.27 Slovenia
- 9.2.28 Malta
- 9.3 Middle East and Africa
- 9.3.1 Saudi Arabia
- 9.3.2 UAE
- 9.3.3 Algeria
- 9.3.4 Iran
- 9.3.5 Turkey
- Chapter 10 Company Profiles
- 10.1 Advancis Medical
- 10.2 B. Braun Melsungen
- 10.3 Baxter International
- 10.4 Coloplast
- 10.5 Convatec Group
- 10.6 Essity
- 10.7 Integra LifeSciences Holdings Corporation
- 10.8 Johnson & Johnson
- 10.9 Medline Industries
- 10.10 Medtronic
- 10.11 Mölnlycke Health Care
- 10.12 Smith & Nephew
- 10.13 URGO Medical
- 10.14 3M Company
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook